氨酸C通过抑制PI3K/AKT/NF-κB信号通路来减轻骨关节炎的发展
Jiawei Hu1, Kai Xiao1, Jianhui Liang2
1Department of Orthopedics, The 1st Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Journal of cellular and molecular medicine
|August 1, 2025
概括
来自Pulsatilla chinensis的Pulchinenoside C (PC) 在骨关节炎 (OA) 治疗中显示出有前途. 这种化合物通过调节关键信号通路来有效减少炎症并保护软骨,这表明它在控制OA进展方面可能发挥治疗作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
- 类风湿病学 类风湿病学
背景情况:
- 骨关节炎 (OA) 是一种退行性关节疾病,其特征是软骨损伤和炎症.
- 炎症通路,包括PI3K/AKT和NF-κB,在OA发育中至关重要.
- 草本提取物由于其多重向和抗炎性质,可以为OA提供潜在的治疗益处.
研究的目的:
- 调查化C (PC) 防止骨关节炎进展的机制.
- 在OA模型中评估PC在调节炎症信号通路中的有效性.
主要方法:
- 在体外:评估PC对IL-1β诱导的ATDC5细胞的抗炎作用,包括矩阵金属蛋白酶表达和细胞外矩阵保护.
- 在体内:利用中介半径 (DMM) 鼠标模型的不稳定性来评估PC对OA发展的影响.
- 在OA模型中研究了PC对PI3K/AKT/NF-κB通路的调节.
主要成果:
- 在实验室中,PC表现出显著的抗炎作用,保护状细胞细胞外基质并抑制基质金属蛋白酶的表达.
- 在体内,PC给药在DMM小鼠模型中阻止了OA的发展.
- 在OA小鼠模型中,PC有效抑制PI3K/AKT/NF-κB通路的激活.
结论:
- 聚化C (PC) 具有强大的抗炎和冠状动脉保护作用,与骨关节炎相关.
- 在OA中,PC的治疗潜力通过抑制PI3K/AKT/NF-κB信号通路进行介导.
- PC代表了一种有前途的,潜在的安全治疗药物,用于治疗骨关节炎.
相关概念视频
NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K


